| Steven C. Quay |
Steven C. Quay is the founder of Nycomed Salutar, Inc. (founded in 1984) and Salutar, Inc. (founded in 1984). He also founded Sonus Pharmaceuticals, Inc. in 1991, where he served as President & Chief Executive Officer until 1999. In 2008, he founded Atossa Therapeutics, Inc. and currently holds the position of Chairman, President & Chief Executive Officer. Dr. Quay's current jobs include being a Member of the American Society for Investigative Pathology, the Association for Molecular Pathology, the Association for Pathology Informatics, Inc., and the Society for Laboratory Automation & Screening. His former jobs include being Chairman, President & Chief Executive Officer of Atossa HealthCare, Inc., Chairman & Chief Scientific Officer of Silverleaf Resorts, Inc., Chairman & President of National Reference Laboratory For Breast Health, Inc., and Director of MDRNA, Inc. from 2000 to 2009. He also served as a Director of VitalMedix, Inc.Dr. Quay's education includes an undergraduate degree from Western Michigan University in 1971 and a doctorate degree from the University of Michigan Medical School in 1977. |
| Arezoo Mirad |
Dr. Arezoo Mirad, MD, is a Senior Director-Medical & Clinical Development at Atossa Therapeutics, Inc. Dr. Mirad was previously employed as a Medical Director by Corcept Therapeutics, Inc. and a Chief Research Analyst by The University of Colorado. She received her graduate degree from The University of North Carolina at Charlotte and a doctorate degree from The University of Colorado. |
| Richard Graydon |
Dr. Richard Graydon is a Chief Medical Officer at Atossa Therapeutics, Inc. Dr. Graydon was previously employed as a Director-Clinical Development by Daiichi Sankyo, Inc. He received his undergraduate degree from Cornell University and a doctorate degree from Stanford University. |
| Shu-Chih Chen |
Shu-Chih Chen is the founder and director at Atossa Therapeutics, Inc., which was founded in 2008. She was also the founder and former president of SC2Q Consulting Co., which was founded in 2006. Dr. Chen's former job includes being the head of cell biology at MDRNA, Inc. from 2002 to 2006. She was also an associate professor at National Yang Ming University and the president of Ensisheim Partners LLC. Dr. Chen holds a doctorate degree from Michigan State University, which she received in 1992, and an undergraduate degree from National Yang Ming University, which she received in 1984. |
| H. Lawrence Remmel |
H. Lawrence Remmel is currently the Director at Cognoptix, Inc., Independent Director at Atossa Therapeutics, Inc., Director at CytoDel LLC, Director at Aufbau Holdings Ltd., and Member of the New York State Bar Association. He was previously a Partner at Pryor Cashman LLP and an Associate at Reboul, MacMurray, Hewitt, Maynard & Kristol and Carter, Ledyard & Milburn LLP. He completed his undergraduate degree at Princeton University in 1975 and his graduate degree at Washington & Lee University School of Law in 1979. |
| Stephen J. Galli |
Stephen J. Galli is an Independent Director at Atossa Therapeutics, Inc., a Professor at Stanford University School of Medicine, and the President of the Association of Pathology Chairs. He was formerly the President of the Collegium Internationale Allergologicum and the American Society for Investigative Pathology. Galli received his doctorate from Harvard Medical School in 1973 and his undergraduate degree from Harvard College in 1968. |
| Richard I. Steinhart |
Richard I. Steinhart is currently an Independent Director at Atossa Therapeutics, Inc., Actinium Pharmaceuticals, Inc., and Chief Financial & Accounting Officer, Senior VP at BioXcel Therapeutics, Inc. He was previously an Independent Director at TG Therapeutics, Inc., Managing Director at Forest Street Capital, LLC, Managing Director at SAE Ventures, CFO & Vice President at Emisphere Technologies, Inc., CFO, Secretary, Treasurer & Senior VP-Finance at STRATA Skin Sciences, Inc., CFO & General Partner at CW Group, Inc., CFO & Vice President at Remedy Pharmaceuticals, Inc., and CFO & SVP-Finance at MELA Sciences Inc. He received his undergraduate and MBA degrees from Pace University. |
